Please assess the completion status of the following clinical trial:

Trial Title: Hyaluronic Acid Gels for Upper Lid Retraction in Active Stage Thyroid Eye Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Active stage TO as determined by symptom onset of under 9 months.~2. Upper eyelid retraction of 1mm or greater in one or both eyes.~3. Complaints of either significant ocular symptoms (despite appropriate use of ocular lubricants), or cosmetic deformity associated with the eyelid retraction.~Exclusion Criteria:~1. Age less than 21 years: due to lack of data on safety for HAG fillers in pediatric population~2. Age over 65 years of age: as HAG filler effect may be different in this population~3. Are pregnant or nursing: as there is little safety data on potential teratogenicity of HAG fillers~4. Have a demonstrated allergy to HAG fillers or lidocaine~5. Have a current infection, skin sore, pimple, rash, hive or cyst over the injection site: to avoid worsening the infection or transmitting it~6. Have a bleeding disorder or currently taking blood thinning medications such as Coumadin, heparin or acetylsalicylic acid on a daily basis.

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Unilateral Upper Eyelid Retraction (Type: EXPERIMENTAL): This arm will consist of participants with unilateral upper eye lid retraction secondary to thyroid eye disease (TED).~Patients enrolled will be randomized 1:1 to Hyaluronic Acid Gel Injection or Saline injection
- Bilateral Upper Eyelid Retraction (Type: EXPERIMENTAL): This arm will consist of participants with bilateral upper eye lid retraction secondary to thyroid eye disease (TED).~Patients enrolled will be randomized 1:1 to Hyaluronic Acid Gel injection or Saline injection

Based on this trial design, predict the completion outcome and termination type (if applicable).